Area of research
Molecular Biology · Genetics
Research interest
Research interests include Glioma Diagnosis and Treatment, Chromatin Remodeling and Cancer, Neuroblastoma Research and Treatments, and Fibroblast Growth Factor Research.
Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti-CD47-induced macrophage phagocytosis via NF-kB-TGM2 driven tumor inflammation
A retrospective analysis of recurrent intracranial ependymoma
A novel tumor-promoting role for nuclear factor IA in glioblastomas is mediated through negative regulation of p53, p21, and PAI1
<i>PID1</i> ( <i>NYGGF4</i> ), a New Growth-Inhibitory Gene in Embryonal Brain Tumors and Gliomas